OKYO Pharma Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of OKYO Pharma Limited generated cash of -$9,490,537, which is less than the previous year. Cash used in financing activities reached the amount of $6,208,508 last year. Net change in cash is therefore -$3,218,533.
Cash Flow
| 2015 | -1.41M | -2.75M | 370.51K |
|---|---|---|---|
| 2016 | -650.88K | -335.17K | 12.35K |
| 2017 | -651.26K | -375.39K | 4.42K |
| 2018 | -1.59M | 0 | 0 |
| 2019 | -1.98M | -1.32K | 0 |
| 2020 | -1.20M | -132.66K | 963.31K |
| 2021 | -1.60M | -18.11K | 7.82M |
| 2022 | -5.46M | -1.66K | 2.15M |
| 2023 | -7.69M | -5.91K | 9.32M |
| 2024 | -9.49M | 0 | 6.20M |
OKYO Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 4.04M | 2.70M | 6.88M | 235.48K | 627.61K | 2.61M | 4.40M | 4.39M | 6.27M | 10.51M |
Operating activities | ||||||||||
Net income | -16.82M | -13.28M | -6.21M | -3.37M | -1.62M | -4.90M | -28.26M | -241.92K | -820.17K | -8.25M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.86K | 3.79K | 2.33K | 13.11K | 5.97K | 217 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 1.11M | 1.27M | 1.71M | 544.38K | 36.34K | 50.53K | 4.23K | 18.37K | 99.20K | 0 |
| Deferred income tax benefit | 1.11M | 1.27M | 1.71M | 544.38K | 36.34K | 50.53K | 4.23K | 18.37K | 99.20K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 440.25K | 167.71K | 27.37K | -2.80K | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.79M | 2.96M | -297.99K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -9.49M | -7.69M | -5.46M | -1.60M | -1.20M | -1.98M | -1.59M | -651.26K | -650.88K | -1.41M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -2 | -5.91K | -1.66K | -6.94K | 0 | -1.32K | 0 | -375.39K | -406.04K | -2.75M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -5.91K | -1.66K | -18.11K | -132.66K | -1.32K | 0 | -375.39K | -335.17K | -2.75M |
Financing activities | ||||||||||
Common Stock Issued | 6.20M | 7.32M | 1.42M | 230.01K | 990.63K | 0 | 0 | 0 | 0 | 238.53K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 2M | 0 | -7.58M | 0 | 0 | 0 | 4.42K | 0 | 0 |
Cash used in financing activities | 6.20M | 9.32M | 2.15M | 7.82M | 963.31K | 0 | 0 | 4.42K | 12.35K | 370.51K |
Net Change In Cash | -3.21M | 1.34M | -4.18M | 6.65M | -392.13K | -1.99M | -1.59M | -651.26K | -1.14M | -4.05M |
Cash at end of period | 826.84K | 4.04M | 2.70M | 6.88M | 235.48K | 627.56K | 2.81M | 3.74M | 5.12M | 6.46M |
| Data source | Data source | Data source |